H.B. Fuller (NYSE:FUL) Receives $75.60 Consensus Target Price from Analysts

Shares of H.B. Fuller (NYSE:FUL) have been assigned an average recommendation of “Hold” from the five analysts that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has given a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $75.60.

Several research firms have commented on FUL. Citigroup lowered their price objective on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. JPMorgan Chase & Co. lowered their price objective on shares of H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating for the company in a research report on Friday, January 17th. Vertical Research lowered shares of H.B. Fuller from a “buy” rating to a “hold” rating in a research report on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of H.B. Fuller from $75.00 to $72.00 and set a “buy” rating for the company in a research report on Wednesday, January 22nd.

H.B. Fuller Price Performance

Shares of NYSE:FUL opened at $60.67 on Tuesday. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.16 and a current ratio of 1.81. The firm has a fifty day moving average price of $64.84 and a 200 day moving average price of $73.74. H.B. Fuller has a fifty-two week low of $59.10 and a fifty-two week high of $87.67. The firm has a market cap of $3.32 billion, a price-to-earnings ratio of 26.27, a P/E/G ratio of 1.17 and a beta of 1.42.

H.B. Fuller (NYSE:FUL) last issued its earnings results on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share for the quarter, missing analysts’ consensus estimates of $1.00 by ($0.08). H.B. Fuller had a return on equity of 12.01% and a net margin of 3.65%. The company had revenue of $923.00 million for the quarter, compared to the consensus estimate of $916.84 million. During the same quarter in the prior year, the company posted $1.32 EPS. H.B. Fuller’s revenue was up 2.2% compared to the same quarter last year. As a group, sell-side analysts expect that H.B. Fuller will post 4.07 earnings per share for the current fiscal year.

H.B. Fuller Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, February 20th. Stockholders of record on Thursday, February 6th will be issued a $0.2225 dividend. The ex-dividend date is Thursday, February 6th. This represents a $0.89 annualized dividend and a dividend yield of 1.47%. H.B. Fuller’s dividend payout ratio (DPR) is presently 38.53%.

Institutional Investors Weigh In On H.B. Fuller

Several institutional investors have recently made changes to their positions in FUL. Lord Abbett & CO. LLC increased its stake in H.B. Fuller by 79.8% in the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock worth $57,952,000 after buying an additional 324,056 shares during the period. Bank of New York Mellon Corp increased its stake in H.B. Fuller by 17.2% in the 4th quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company’s stock worth $37,448,000 after buying an additional 81,558 shares during the period. Amundi increased its stake in H.B. Fuller by 191.9% in the 4th quarter. Amundi now owns 28,553 shares of the specialty chemicals company’s stock worth $1,804,000 after buying an additional 18,771 shares during the period. Geode Capital Management LLC increased its stake in H.B. Fuller by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock worth $99,939,000 after buying an additional 18,734 shares during the period. Finally, Kennedy Capital Management LLC increased its stake in H.B. Fuller by 13.4% in the 4th quarter. Kennedy Capital Management LLC now owns 127,896 shares of the specialty chemicals company’s stock worth $8,630,000 after buying an additional 15,100 shares during the period. Institutional investors own 95.93% of the company’s stock.

H.B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.